SMURF2 and cancer: GSTP1 provides a GPX4- and FSP1-independent defense against ferroptosis by detoxifying lipid hydroperoxides, and its degradation via the SMURF2/GSTP1 axis sensitizes cancer cells to ferroptosis-inducing drugs and immune checkpoint inhibitors